Atreca shares are trading lower after the company reported Q2 financial results. Additionally, HC Wainwright downgraded the stock from Buy to Neutral, while Stifel downgraded the stock from Buy to Hold and lowered its price target from $4 to $1.
Portfolio Pulse from Benzinga Newsdesk
Atreca reported Q2 financial results, leading to a drop in its share price. The stock was downgraded by HC Wainwright from Buy to Neutral and by Stifel from Buy to Hold. Stifel also lowered its price target from $4 to $1.
August 11, 2023 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atreca's Q2 financial results and subsequent downgrades by HC Wainwright and Stifel have led to a decrease in its share price.
Atreca's Q2 financial results were not favorable, leading to a drop in its share price. This was further exacerbated by downgrades from HC Wainwright and Stifel, with Stifel also lowering its price target for the stock. This combination of factors is likely to have a negative impact on Atreca's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100